| Financial Year |
March 31 2023 |
| Monetary Funds |
6,026,537,732.47 |
| Held-for-trading Financial Assets |
834,735,459.88 |
| Notes Receivable |
450,972,059.73 |
| Accounts Receivable |
3,452,851,245.75 |
| Advances to Suppliers |
114,149,854.47 |
| Other Receivables |
1,742,957,694.79 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,128,774,580.25 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
6,000,000.00 |
| Other Current Assets |
500,115,501.11 |
| Total Current Assets |
15,768,611,310.76 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
1,787,562.70 |
| Investment Properties |
18,076,443.88 |
| Fixed Assetes |
5,549,025,326.13 |
| Under-construction Projects |
1,958,760,107.89 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
490,208,044.21 |
| R&D expenses |
-- |
| Goodwill |
490,638,577.84 |
| Long-Term Deferred and Prepaid Expenses |
26,450,222.75 |
| Deferred Income Tax Assets |
4,773,767.71 |
| Other Non-Current Assets |
436,644,317.16 |
| Sub-Total of Non-Current Assets |
10,958,059,558.55 |
| Total Assets |
26,726,670,869.31 |
| Short-Term Loans |
4,147,301,332.37 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,515,244,713.36 |
| Accounts Payable |
1,716,876,072.94 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
113,960,823.95 |
| Taxes Payable |
38,651,105.09 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
322,510,093.62 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
907,495,736.08 |
| Other Current Liabilities |
7,998,548.45 |
| Sub-Total of Current Liabilities |
8,864,581,368.60 |
| Long-term Loans |
1,238,368,197.32 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
1,150,000,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
7,150,000.00 |
| Deferred Income Tax Liabilities |
290,066,882.25 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
3,572,813,931.69 |
| Total Liabilities |
12,437,395,300.29 |
| Paid-In Capital(Or Share Stock) |
4,526,940,607.00 |
| Capital Surplus |
910,301,312.78 |
| Surplus Reserve |
711,618,031.43 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
8,000,706,257.07 |
| Minority Stockholder's Interest |
293,296,729.58 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
13,995,978,839.44 |
| Owner's Equity（Stockholder's Equity） |
14,289,275,569.02 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
26,726,670,869.31 |
